Evidence map›Paper›PMID 38892291›Full record

ReviewInternational journal of molecular sciences2024

Translational Experimental Basis of Indirect Adenosine Receptor Agonist Stimulation for Bone Regeneration: A Review.

Quinn T Ehlen, Nicholas A Mirsky, Blaire V Slavin, Marcelo Parra, Vasudev Vivekanand Nayak, Bruce Cronstein, Lukasz Witek, Paulo G Coelho

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Special Issue "Adenosine Receptors in Health and Disease".International journal of molecular sciences · 2024
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Quinn T EhlenUniversity of Miami Miller School of Medicine, Miami, FL 33136, USA.
Nicholas A MirskyUniversity of Miami Miller School of Medicine, Miami, FL 33136, USA.
Blaire V SlavinUniversity of Miami Miller School of Medicine, Miami, FL 33136, USA.
Marcelo ParraCenter of Excellence in Morphological and Surgical Studies (CEMyQ), Faculty of Medicine, Universidad de la Frontera, Temuco 4811230, Chile.
Vasudev Vivekanand NayakDepartment of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.ORCID 0000-0003-2739-0339
Bruce CronsteinDepartment of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA.
Lukasz WitekBiomaterials Division, NYU Dentistry, New York, NY 10010, USA.ORCID 0000-0003-1458-6527
Paulo G CoelhoDepartment of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

Funding

Purinergic Stimulation of Bone RegenerationR01AR068593 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COELHO, PAULO G, CRONSTEIN, BRUCE NEIL · 2015 to 2019
$2.8M
Engineering Personalized Devices for Craniomaxillofacial DefectsR33HD090664 · NICHD · NEW YORK UNIVERSITY · PI CRONSTEIN, BRUCE NEIL, FLORES, ROBERTO L · 2019 to 2021
$1.2M
NIAMS NIH HHS R01 AR068593NICHD NIH HHS R33 HD090664
6 · The paper itself

Abstract

Bone regeneration remains a significant clinical challenge, often necessitating surgical approaches when healing bone defects and fracture nonunions. Within this context, the modulation of adenosine signaling pathways has emerged as a promising therapeutic option, encouraging osteoblast activation and tempering osteoclast differentiation. A literature review of the PubMed database with relevant keywords was conducted. The search criteria involved in vitro or in vivo models, with clear methodological descriptions. Only studies that included the use of indirect adenosine agonists, looking at the effects of bone regeneration, were considered relevant according to the eligibility criteria. A total of 29 articles were identified which met the inclusion and exclusion criteria, and they were reviewed to highlight the preclinical translation of adenosine agonists. While preclinical studies demonstrate the therapeutic potential of adenosine signaling in bone regeneration, its clinical application remains unrealized, underscoring the need for further clinical trials. To date, only large, preclinical animal models using indirect adenosine agonists have been successful in stimulating bone regeneration. The adenosine receptors (A

Indexed as

Bone RegenerationPurinergic P1 Receptor AgonistsReceptors, Purinergic P1AdenosineAnimalsHumansSignal TransductionTranslational Research, BiomedicalAdenosinePurinergic P1 Receptor AgonistsReceptors, Purinergic P1adenosinebone regenerationdipyridamoleindirect agonist

Identifiers

PMID38892291
PMCPMC11172580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.